Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

283 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bisphosphonates.
Diez-Perez A. Diez-Perez A. Maturitas. 2002 Aug 30;43 Suppl 1:S19-26. doi: 10.1016/s0378-5122(02)00145-7. Maturitas. 2002. PMID: 12361885 Review. No abstract available.
Selective estrogen receptor modulators (SERMS).
Diez-Perez A. Diez-Perez A. Arq Bras Endocrinol Metabol. 2006 Aug;50(4):720-34. doi: 10.1590/s0004-27302006000400017. Arq Bras Endocrinol Metabol. 2006. PMID: 17117297
Official Positions for FRAX® Bone Mineral Density and FRAX® simplification from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.
Lewiecki EM, Compston JE, Miller PD, Adachi JD, Adams JE, Leslie WD, Kanis JA, Moayyeri A, Adler RA, Hans DB, Kendler DL, Diez-Perez A, Krieg MA, Masri BK, Lorenc RR, Bauer DC, Blake GM, Josse RG, Clark P, Khan AA; FRAX® Position Development Conference Members. Lewiecki EM, et al. J Clin Densitom. 2011 Jul-Sep;14(3):226-36. doi: 10.1016/j.jocd.2011.05.017. J Clin Densitom. 2011. PMID: 21810530
Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
Siris ES, Harris ST, Eastell R, Zanchetta JR, Goemaere S, Diez-Perez A, Stock JL, Song J, Qu Y, Kulkarni PM, Siddhanti SR, Wong M, Cummings SR; Continuing Outcomes Relevant to Evista (CORE) Investigators. Siris ES, et al. J Bone Miner Res. 2005 Sep;20(9):1514-24. doi: 10.1359/JBMR.050509. Epub 2005 May 16. J Bone Miner Res. 2005. PMID: 16059623 Free article. Clinical Trial.
Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.
Liu JL, Zhu HM, Huang QR, Zhang ZL, Li HL, Qin YJ, Zhang Y, Wei DL, Lu JH, Liu H, Chen XP, Liu YJ, Ekangaki A, Zheng YM, Diez-Perez A, Harper K. Liu JL, et al. Chin Med J (Engl). 2004 Jul;117(7):1029-35. Chin Med J (Engl). 2004. PMID: 15265377 Clinical Trial.
283 results